GLP-1 Research
Ozempic's maximum approved dose is 2 mg weekly for diabetes and 2.4 mg weekly for weight loss under…
Semaglutide exists under three brand names — Ozempic, Wegovy, and Rybelsus — each with distinct doses, delivery methods,…
Semaglutide (Ozempic) can be used by non-diabetic men off-label or through Wegovy, but clinical evidence shows results depend…
Tirzepatide's dual GIP/GLP-1 receptor mechanism delivers unprecedented weight loss outcomes, but the science also reveals critical muscle preservation…
A deep dive into the clinical evidence behind Ozempic for type 2 diabetes — how it works, what…
GLP-1 medications like semaglutide and tirzepatide can cause the equivalent of 20 years of muscle loss — here's…
New research reveals GLP-1 medications may improve testosterone levels in men with metabolic dysfunction — but the mechanism…
New research reveals tirzepatide drives powerful fat loss and visceral fat reduction, but also significant lean mass loss…
Up to 45% of weight lost on semaglutide can come from muscle — here is what the latest…
A comprehensive breakdown of what the latest GLP-1 research — including the 2025 STRIDE trial — reveals about…